| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.047 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |